Ontology highlight
ABSTRACT:
SUBMITTER: Kadowaki T
PROVIDER: S-EPMC5484989 | biostudies-literature | 2017 Jun
REPOSITORIES: biostudies-literature
Diabetes, obesity & metabolism 20170331 6
<h4>Aims</h4>To investigate efficacy and safety of the sodium-glucose co-transporter 2 (SGLT2) inhibitor canagliflozin administered as add-on therapy to the dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin in patients with type 2 diabetes mellitus (T2DM).<h4>Materials and methods</h4>We conducted a multicentre, randomized, double-blind, placebo-controlled, phase 3 clinical trial in Japanese patients with T2DM who had inadequate glycaemic control with teneligliptin. Patients were randomized ...[more]